Amyloidosis of the Lung

  • Karen L. Grogg
  • Oana Madalina Mereuta
  • Ahmet DoganEmail author
Part of the Current Clinical Pathology book series (CCPATH)


Amyloidosis involving the lung may represent a systemic disease or a localized process. Despite the common etiology (i.e., deposition of abnormal immunoglobulin proteins designated as AL type), each condition is characterized by distinct clinicopathological features as well as specific treatment and prognosis. Three main histologic presentations are described: nodular pulmonary amyloidosis (NPA), tracheobronchial amyloidosis, both forms limited to the lung, and diffuse alveolar septal amyloidosis which is commonly associated with systemic disease. Detailed biochemical composition of the amyloid deposits involving the lung obtained by proteomic analysis and correlation with immunohistochemistry (IHC) may provide new insights into pathogenesis of the localized pulmonary amyloidosis. Therefore, we highlight herein that most of the NPA cases show codeposition of heavy and light chain immunoglobulins (AL/AH type) and are associated with a lymphoplasmacytic neoplasm in the spectrum of mucosa-associated lymphoid tissue (MALT) lymphoma.


Lung amyloidosis Nodular pulmonary amyloidosis Immunoglobulins light and heavy chains Mucosa-associated lymphoid tissue lymphoma Proteomic analysis 


  1. 1.
    Buxbaum JN. The amyloidoses. In: Goldman L, Ausiello D, editors. Cecil medicine. 23rd ed. Philadelphia, PA: Saunders Elsevier; 2008. p. 2083–7.Google Scholar
  2. 2.
    Howard ME, Ireton J, Daniels F, et al. Pulmonary presentations of amyloidosis. Respirology. 2001;6:61–4.CrossRefPubMedGoogle Scholar
  3. 3.
    Utz JP, Swensen SJ, Gertz MA. Pulmonary amyloidosis. The Mayo Clinic experience from 1980 to 1993. Ann Intern Med. 1996;124:407–13.CrossRefPubMedGoogle Scholar
  4. 4.
    Roden AC, Aubry MC, Zhang K, et al. Nodular senile pulmonary amyloidosis: a unique case confirmed by immunohistochemistry, mass spectrometry, and genetic study. Hum Pathol. 2010;41:1040–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Sumiya M, Ohya N, Shinoura H, et al. Diffuse interstitial pulmonary amyloidosis in rheumatoid arthritis. J Rheumatol. 1996;23:933–6.PubMedGoogle Scholar
  6. 6.
    Poh SC, Tija TS, Seah HC. Primary diffuse alveolar septal amyloidosis. Thorax. 1975;30:186–91.PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Celli BR, Rubinow A, Cohen AS, Brody JS. Patterns of pulmonary involvement in systemic amyloidosis. Chest. 1978;74:543–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Chan ED, Morales DV, Welsh CH, et al. Calcium deposition with or without bone formation in the lung. Am J Respir Crit Care Med. 2002;165:1654–69.CrossRefPubMedGoogle Scholar
  9. 9.
    Smith RR, Hutchins GM, Moore GW, et al. Type and distribution of pulmonary parenchymal and vascular amyloid. Correlation with cardiac amyloid. Am J Med. 1979;66:96–104.CrossRefPubMedGoogle Scholar
  10. 10.
    Ueda M, Ando Y, Haraoka K, et al. Aging and transthyretin-related amyloidosis: pathologic examinations in pulmonary amyloidosis. Amyloid. 2006;13:24–30.CrossRefPubMedGoogle Scholar
  11. 11.
    Westermark P, Bergström J, Solomon A, et al. Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid. 2003;10 Suppl 1:48–54.PubMedGoogle Scholar
  12. 12.
    Cordier JF, Loire R, Brune J. Amyloidosis of the lower respiratory tract. Clinical and pathologic features in a series of 21 patients. Chest. 1986;90:827–31.CrossRefPubMedGoogle Scholar
  13. 13.
    Bergström J, Murphy C, Eulitz M, et al. Codeposition of apolipoprotein A-IV and transthyretin in senile systemic (ATTR) amyloidosis. Biochem Biophys Res Commun. 2001;285:903–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Bergström J, Murphy CL, Weiss DT, et al. Two different types of amyloid deposits-apolipoprotein A-IV and transthyretin-in a patient with systemic amyloidosis. Lab Invest. 2004;84:981–9888.CrossRefPubMedGoogle Scholar
  15. 15.
    Hui AN, Koss MN, Hochholzer I, Wehunt WD. Amyloidosis presenting in the lower respiratory tract. Clinicopathologic, radiologic, immunohistochemical and histochemical studies on 48 cases. Arch Pathol Lab Med. 1986;110:212–8.PubMedGoogle Scholar
  16. 16.
    Vrana JA, Gamez JD, Madden BJ, et al. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood. 2009;114:4957–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Ahamed MF, Giampitri EA, Al Shamy A. Pulmonary amyloidosis in a patient with lymphocytic interstitial pneumonia. Ann Saudi Med. 2007;27:40–4.CrossRefPubMedGoogle Scholar
  18. 18.
    Adzic TN, Stojsic JM, Radosavljevic-Asic GD, et al. Multinodular pulmonary amyloidosis in primary Sjogren’s syndrome. Eur J Intern Med. 2008;19:e97–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Rodriguez K, Neves F, Stoeterau K, et al. Pulmonary amyloidosis in Sjogren’s syndrome: a rare diagnosis for nodular lung lesions. Int J Rheum Dis. 2009;12:358–60.CrossRefGoogle Scholar
  20. 20.
    Kawashiri SY, Tamai M, Yamasaki S, et al. A case of Sjogren syndrome with pulmonary amyloidosis complicating microscopic polyangiitis. Mod Rheumatol. 2011;21:646–50.CrossRefPubMedGoogle Scholar
  21. 21.
    Beer TW, Edwards CW. Pulmonary nodules due to reactive systemic amyloidosis (AA) in Crohn’s disease. Thorax. 1993;48:1287–8.PubMedCentralCrossRefPubMedGoogle Scholar
  22. 22.
    Gordonson JS, Sargent EN, Jacobson G, et al. Roentgenographic manifestations of pulmonary amyloidosis (classification and case illustrations). J Can Assoc Radiol. 1972;23:269–72.PubMedGoogle Scholar
  23. 23.
    Ayuso MC, Gilabert R, Bombi JA, et al. CT appearance of localized pulmonary amyloidosis. J Comput Assist Tomogr. 1987;11:197–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Grogg KL, Aubry MC, Vrana JA, et al. Nodular pulmonary amyloidosis is characterized by localized immunoglobulin deposition and is frequently associated with an indolent B-cell lymphoproliferative disorder. Am J Surg Pathol. 2013;37:406–12.CrossRefPubMedGoogle Scholar
  25. 25.
    Kaplan B, Martin BM, Boykov O, et al. Co-deposition of amyloidogenic immunoglobulin light and heavy chains in localized pulmonary amyloidosis. Virchows Arch. 2005;447:756–61.CrossRefPubMedGoogle Scholar
  26. 26.
    Morice WG, Chen D, Kurtin PJ, et al. Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenstrom’s macroglobulinemia. Mod Pathol. 2009;22:807–16.PubMedGoogle Scholar
  27. 27.
    Dacic S, Colby TV, Yousem SA. Nodular amyloidoma and primary pulmonary lymphoma with amyloid production: a differential diagnostic problem. Mod Pathol. 2000;13:934–40.CrossRefPubMedGoogle Scholar
  28. 28.
    Moriyama E, Yokose T, Kodama T, et al. Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue in the thymus of a patient with pulmonary amyloid nodules. Jpn J Clin Oncol. 2000;30:349–53.CrossRefPubMedGoogle Scholar
  29. 29.
    Kurtin PJ, Myers JL, Adlakha H, et al. Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am J Surg Pathol. 2001;25:997–1008.CrossRefPubMedGoogle Scholar
  30. 30.
    Lim JK, Lacy MQ, Kurtin PJ, et al. Pulmonary marginal zone lymphoma of MALT type as a cause of localized pulmonary amyloidosis. J Clin Pathol. 2001;54:642–6.PubMedCentralCrossRefPubMedGoogle Scholar
  31. 31.
    Hourseau M, Virally J, Habib E, et al. Nodular amyloidoma associated with primary pulmonary Malt lymphoma. Rev Mal Respir. 2008;25:1123–6.CrossRefPubMedGoogle Scholar
  32. 32.
    Wey S-J, Chen Y-M, Lai P-J, et al. Primary Sjogren syndrome manifested as localized cutaneous nodular amyloidosis. J Clin Rheumatol. 2011;17:368–70.CrossRefPubMedGoogle Scholar
  33. 33.
    Wohrer S, Troch M, Streubel B, et al. MALT lymphoma in patients with autoimmune diseases: a comparative analysis of characteristics and clinical course. Leukemia. 2007;21:1812–8.CrossRefPubMedGoogle Scholar
  34. 34.
    Streubel B, Huber D, Wohrer S, et al. Frequency of chromosomal aberrations involving MALT1 in mucosa-associated lymphoid tissue lymphoma in patients with Sjogren’s syndrome. Clin Cancer Res. 2004;10:476–80.CrossRefPubMedGoogle Scholar
  35. 35.
    Remstein ED, Dogan A, Einerson RR, et al. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America. Am J Surg Pathol. 2006;30:1546–53.CrossRefPubMedGoogle Scholar
  36. 36.
    Chng WJ, Remstein ED, Fonseca R, et al. Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications. Blood. 2009;113:635–45.PubMedCentralCrossRefPubMedGoogle Scholar
  37. 37.
    Raderer M, Streubel B, Woehrer S, et al. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res. 2005;11:3349–52.CrossRefPubMedGoogle Scholar
  38. 38.
    Sakai M, Yamaoka M, Kawaguchi M, et al. Multiple cystic pulmonary amyloidosis. Ann Thorac Surg. 2011;92:e109.CrossRefPubMedGoogle Scholar
  39. 39.
    Baqir M, Kluka EM, Aubry MC, et al. Amyloid-associated cystic lung disease in primary Sjogren’s syndrome. Respir Med. 2013;107:616–21.CrossRefPubMedGoogle Scholar
  40. 40.
    Chew KM, Clarke MJ, Dubey N, et al. Nodular pulmonary amyloidosis with unusual, widespread lung cysts. Singapore Med J. 2013;54:e97–9.CrossRefPubMedGoogle Scholar
  41. 41.
    Kirchner J, Jacobi V, Kardos P, et al. CT findings in extensive tracheobronchial amyloidosis. Eur Radiol. 1998;8:352–4.CrossRefPubMedGoogle Scholar
  42. 42.
    Thompson PJ, Ryan G, Laurence BH. Laser photoradiation therapy for tracheobronchial amyloid. Aust N Z J Med. 1986;16:229–30.CrossRefPubMedGoogle Scholar
  43. 43.
    Woo KS, van Hasselt CA, Waldron J. Laser resection of localized subglottic amyloidosis. J Otolaryngol. 1990;19:337–8.PubMedGoogle Scholar
  44. 44.
    Buxbaum J, Gallo G. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases. Hematol Oncol Clin North Am. 1999;13:1235–48.CrossRefPubMedGoogle Scholar
  45. 45.
    Lin J, Markowitz GS, Valeri AM, et al. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol. 2001;12:1482–92.PubMedGoogle Scholar
  46. 46.
    Khoor A, Myers JL, Tazelaar HD, Kurtin PJ. Amyloid-like pulmonary nodules, including localized light-chain deposition: clinicopathologic analysis of three cases. Am J Clin Pathol. 2004;121:200–4.CrossRefPubMedGoogle Scholar
  47. 47.
    Bhargava P, Rushin JM, Rusnock EJ, et al. Pulmonary light chain deposition disease: report of five cases and review of the literature. Am J Surg Pathol. 2007;31:267–76.CrossRefPubMedGoogle Scholar
  48. 48.
    Colombat M, Stern M, Groussard O, et al. Pulmonary cystic disorder related to light chain deposition disease. Am J Respir Crit Care Med. 2006;173:777–80.CrossRefPubMedGoogle Scholar
  49. 49.
    Colombat M, Mal H, Copie-Bergman C, et al. Primary cystic lung light chain deposition disease: a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor. Blood. 2008;112:2004–12.PubMedCentralCrossRefPubMedGoogle Scholar
  50. 50.
    Colombat M, Caudroy S, Lagonotte E, et al. Pathomechanisms of cyst formation in pulmonary light chain deposition disease. Eur Respir J. 2008;32:1399–403.CrossRefPubMedGoogle Scholar
  51. 51.
    Jones D, Bhatia VK, Krausz T, Pinkus GS. Crystal-storing histiocytosis: a disorder occurring in plasmacytic tumors expressing immunoglobulin kappa light chain. Hum Pathol. 1999;30:1441–8.CrossRefPubMedGoogle Scholar
  52. 52.
    Dogan S, Barnes L, Cruz-Vetrano WP. Crystal-storing histiocytosis: report of a case, review of the literature (80 cases) and a proposed classification. Head Neck Pathol. 2012;6:111–20.PubMedCentralCrossRefPubMedGoogle Scholar
  53. 53.
    Lebeau A, Zeindl-Eberhart E, Muller E-C, et al. Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of literature. Blood. 2002;100:1817–27.PubMedGoogle Scholar
  54. 54.
    Tahara K, Miyajima K, Ono M, et al. Crystal-storing histiocytosis associated with marginal-zone lymphoma. Jpn J Radiol. 2014;32(5):296–301.CrossRefPubMedGoogle Scholar
  55. 55.
    Rossi G, Morandi U, Nannini N, et al. Crystal-storing histiocytosis presenting with pleural disease. Histopathology. 2010;56(3):403–5.CrossRefPubMedGoogle Scholar
  56. 56.
    Rossi G, De Rosa N, Cavazza A, et al. Localized pleuropulmonary crystal-storing histiocytosis: 5 cases of a rare histiocytic disorder with variable clinicoradiologic features. Am J Surg Pathol. 2013;37(6):906–12.CrossRefPubMedGoogle Scholar
  57. 57.
    Zhang C, Myers JL. Crystal-storing histiocytosis complicating primary pulmonary marginal zone lymphoma of mucosa-associated lymphoid tissue. Arch Pathol Lab Med. 2013;137:1199–204.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Karen L. Grogg
    • 1
  • Oana Madalina Mereuta
    • 2
  • Ahmet Dogan
    • 3
    Email author
  1. 1.Department of Laboratory Medicine and PathologyMayo ClinicRochesterUSA
  2. 2.Department of PathologyMemorial Sloan Kettering Cancer CenterNew YorkUSA
  3. 3.Departments of Pathology and Laboratory MedicineMemorial Sloan Kettering Cancer CenterNew YorkUSA

Personalised recommendations